Opendata, web and dolomites

PFS SIGNED

A cost- energy-efficient treatment technology to remove pharmaceutical pollutants from water

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PFS project word cloud

Explore the words cloud of the PFS project. It provides you a very rough idea of what is the project "PFS" about.

patented    prescription    market    investments    feasibility    25bn    successful    facilities    organic    roll    installed    resistant    counter    compact    water    easily    posing    34m    wastewater    alternative    drinking    revenue    upcoming    07m    compounds    pharem    temperature    medicines    biological    disruptors    pfs    pharmaceuticals    times    pollutants    public    deploy    biotech    health    globally    trial    urban    widely    active    100bn    antibiotics    levels    chemicals    200    solution    native    modern    plants    designed    therapeutic    contribution    validated    purification    supply    day    stability    filtration    validate    removing    enzymes    brings    treatment    threats    ec    requested    first    drugs    modified    2020    prepare    industrialize    ph    natural    removal    legislation    enzyme    markets    bisphenol    yearly    veterinary    synthetic    serious    infrastructure    2015    mandatory    commercial    total    hormone    run    size    litres    efficient    found    energy   

Project "PFS" data sheet

The following table provides information about the project.

Coordinator
PHAREM BIOTECH AB 

Organization address
address: LEVERTINSGATAN 30-1202
city: UPPSALA
postcode: 754 30
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website https://www.pharem.se/wastewater-2/
 Total cost 2˙962˙500 €
 EC max contribution 2˙073˙750 € (70%)
 Programme 1. H2020-EU.3.5. (SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-2-2016-2017
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PHAREM BIOTECH AB SE (UPPSALA) coordinator 2˙073˙750.00

Map

 Project objective

Widely used pharmaceuticals (synthetic or natural chemicals found in prescription medicines, over-the-counter therapeutic drugs & veterinary drugs) are finding their way into the drinking water supply via wastewater treatment facilities, posing serious threats to public health globally. The problem is that modern wastewater treatment facilities are not designed for effective removal of pharmaceuticals or similar organic compounds. Upcoming EU legislation will make such removal mandatory. Pharem Biotech brings to market PFS—the first patented enzyme-carrying filtration system capable of removing a large range of organic pollutants (pharmaceuticals and other biological active compounds such as bisphenol A, antibiotics, hormone disruptors, etc.). PFS is a filtration solution that can be easily installed at most of wastewater treatment facilities. Its compact size makes it particularly useful for urban wastewater treatment plants. PFS is based on modified enzymes which are 200 times more effective than native enzymes, resistant to low temperature, resistant to low pH and with high levels of stability and activity. Compared to alternative purification methods, PFS is very cost-efficient, and requires no energy to run. As the total EU yearly investments in its wastewater treatment facilities and related infrastructure are expected to reach €25bn per year in 2015-2020, Pharem Biotech is addressing the market of 70,000 facilities in EU processing 100bn litres of water per day in total. During a successful Phase 1 project, Pharem Biotech validated the market and commercial feasibility of PFS, and selected the trial cases to validate the technology as well as key target markets to approach. In this Phase 2 project Pharem Biotech will industrialize PFS, validate it in trial cases and prepare for commercial roll out with the objective is to deploy 50 PFS systems before 2020 and reach revenue of €34m. The requested EC contribution is €2.07m.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PFS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PFS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.5.;H2020-EU.2.3.1.)

DUSTCOMB (2018)

A Novel Technology to Reduce Industrial Dust Pollution and to Enable Most Efficient Energy Recovery

Read More  

CleanCoat (2017)

Development of eco-friendly architectural coil coatings for clean buildings and pollution-free air

Read More  

PAIR (2015)

Plasma active pollution control system

Read More